C7291

Clomipramin -hydrochlorid

≥98% (HPLC), powder

• Synonym(e): 3-Chlor-10,11-dihydro-N,N-dimethyl-5H-dibenz[b,f]azepin-5-propanamin -hydrochlorid, Anafranil -hydrochlorid
• Empirische Formel (Hill-System): C₁₉H₂₃ClN₂ · HCl
• CAS-Nummer: 17321-77-6
• Molekulargewicht: 351.31
• EG-Nummer: 241-344-3
• MDL-Nummer: MFCD00069234
• UNSPSC-Code: 12352116
• PubChem Substanz-ID: 24278087
• NACRES: NA.77

Eigenschaften

• Qualitätsniveau: 200
• Assay: ≥98% (HPLC)
• Form: powder
• Farbe: white to off-white
• Löslichkeit: H₂O: 25 mg/mL; 0.1 M HCl: soluble
• Ersteller: Novartis
• SMILES String: Cl.CN(C)CCCN1c2ccccc2CCc3ccc(Cl)cc13
• InChI: 1S/C19H23ClN2.ClH/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22;/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3;1H
• InChIKey: WIMWMKZEIBHDTH-UHFFFAOYSA-N
• Angaben zum Gen: human ... HTR1A(3350) , HTR1B(3351) , HTR1D(3352) , HTR1E(3354) , HTR1F(3355) , HTR2A(3356) , HTR2B(3357) , HTR2C(3358) , HTR3A(3359) , HTR3B(9177) , HTR3C(170572) , HTR3D(200909) , HTR3E(285242) , HTR4(3360) , HTR5A(3361) , HTR5B(645694) , HTR6(3362) , HTR7(3363) , SLC6A4(6532)

Beschreibung

Allgemeine Beschreibung

Clomipramine hydrochloride is an antiobsessional drug. It has anticholinergic activity in vitro and in vivo. Clomipramine is used to treat obsessive compulsive disorder and panic disorder.

Anwendung

Clomipramine hydrochloride has been used to manipulate serotonin (5-HT) mechanisms. It has also been used to study its role on bone mass.

Clomipramine hydrochloride has been used:

• to study its effect on human serum albumin using UV-visible, fluorescence and circular dichroism (CD) techniques
• to block itchy E3 ubiquitin protein ligase (ITCH) ubiquitin transthiolation
• as a serotonin reuptake inhibitor
• as a homologous to E6AP C terminus (HECT) E3 ligase inhibitor

Biochem./physiol. Wirkung

Clomipramine hydrochloride (CLP) is a amphiphilic drug, with two benzene rings in its structure. It exhibits anti-depressant property by restoring the equilibrium of certain natural materials in the human being. CLP acts as a potential therapeutic for obsessive compulsive disorder.

Tricyclic antidepressant; inhibits serotonin and norepinephrine transporters.

Leistungsmerkmale und Vorteile

This compound is featured on the Biogenic Amine Transporters page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Sicherheitshinweise

• Piktogramme: GHS08,GHS07,GHS09
• Signalwort: Danger
• H-Sätze: H302,H336,H370,H410
• P-Sätze: P260 - P264 - P271 - P273 - P301 + P312 - P308 + P311
• Gefahreneinstufungen: Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - STOT SE 1 - STOT SE 3
• Zielorgane: Central nervous system, Central nervous system,Cardiovascular
• Lagerklassenschlüssel: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• Persönliche Schutzausrüstung: dust mask type N95 (US), Eyeshields, Gloves